The Good, The Bad, And The Uncertain: Trump’s Second Administration And The Rx Industry

 
• By Nielsen Hobbs
  
With Trump’s return, pharma trades a disagreeable White House for an unpredictable one (Shutterstock)

More from Outlook

More from Global Vision